Sunflower Pharmaceutical Group Co.,Ltd (SHE: 002737)

Sunflower Pharmaceutical Group Co.,Ltd Statistics

Total Valuation

Sunflower Pharmaceutical Group Co.,Ltd has a market cap or net worth of CNY 11.69 billion. The enterprise value is 9.42 billion.

Market Cap	11.69B
Enterprise Value	9.42B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 14, 2024

Share Statistics

Sunflower Pharmaceutical Group Co.,Ltd has 584.00 million shares outstanding. The number of shares has decreased by -0.37% in one year.

Shares Outstanding	584.00M
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	+2.06%
Owned by Insiders (%)	7.06%
Owned by Institutions (%)	10.81%
Float	250.60M

Valuation Ratios

The trailing PE ratio is 12.12.

PE Ratio	12.12
Forward PE	n/a
PS Ratio	2.26
PB Ratio	2.67
P/FCF Ratio	46.10
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.30, with an EV/FCF ratio of 37.17.

EV / Earnings	9.74
EV / Sales	1.81
EV / EBITDA	8.30
EV / EBIT	9.64
EV / FCF	37.17

Financial Position

The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.00.

Current Ratio	3.28
Quick Ratio	2.45
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.05
Interest Coverage	426.69

Financial Efficiency

Return on equity (ROE) is 21.99% and return on invested capital (ROIC) is 13.31%.

Return on Equity (ROE)	21.99%
Return on Assets (ROA)	9.58%
Return on Capital (ROIC)	13.31%
Revenue Per Employee	899,232
Profits Per Employee	167,471
Employee Count	5,776
Asset Turnover	0.81
Inventory Turnover	2.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.03% in the last 52 weeks. The beta is 0.31, so Sunflower Pharmaceutical Group Co.,Ltd's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-12.03%
50-Day Moving Average	21.39
200-Day Moving Average	25.06
Relative Strength Index (RSI)	44.12
Average Volume (20 Days)	9,770,515

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sunflower Pharmaceutical Group Co.,Ltd had revenue of CNY 5.19 billion and earned 967.32 million in profits. Earnings per share was 1.65.

Revenue	5.19B
Gross Profit	2.82B
Operating Income	977.76M
Pretax Income	1.18B
Net Income	967.32M
EBITDA	1.13B
EBIT	977.76M
Earnings Per Share (EPS)	1.65

Balance Sheet

The company has 2.50 billion in cash and 11.51 million in debt, giving a net cash position of 2.49 billion or 4.27 per share.

Cash & Cash Equivalents	2.50B
Total Debt	11.51M
Net Cash	2.49B
Net Cash Per Share	4.27
Equity (Book Value)	4.61B
Book Value Per Share	7.50
Working Capital	2.94B

Cash Flow

In the last 12 months, operating cash flow was 371.75 million and capital expenditures -118.24 million, giving a free cash flow of 253.51 million.

Operating Cash Flow	371.75M
Capital Expenditures	-118.24M
Free Cash Flow	253.51M
FCF Per Share	0.43

Margins

Gross margin is 54.29%, with operating and profit margins of 18.83% and 18.62%.

Gross Margin	54.29%
Operating Margin	18.83%
Pretax Margin	22.70%
Profit Margin	18.62%
EBITDA Margin	21.75%
EBIT Margin	18.82%
FCF Margin	4.88%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 7.02%.

Dividend Per Share	1.50
Dividend Yield	7.02%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	2
Payout Ratio	90.85%
Buyback Yield	0.37%
Shareholder Yield	7.39%
Earnings Yield	8.25%
FCF Yield	2.17%

Stock Splits

The last stock split was on April 18, 2018. It was a forward split with a ratio of 2.

Last Split Date	Apr 18, 2018
Split Type	Forward
Split Ratio	2

Scores

Sunflower Pharmaceutical Group Co.,Ltd has an Altman Z-Score of 7.96.

Altman Z-Score	7.96
Piotroski F-Score	n/a